Tibolone

替勃龙

Report date: 2025/11/18 14:52:20
NME

Base Information

Drug NameTibolone
Drug Alias Name甲基异炔诺酮7-甲异炔诺酮Liviella利维爱Boltin +[9] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionEstrogen receptors agonists
TargetsEstrogen receptors
Therapy Area/IndicationsMenopausal symptomsSexual Dysfunction, PhysiologicalOsteoporosis, Postmenopausal +[5] 
Global Approved IndicationsMenopausal symptoms
Approved Indications in ChinaMenopausal symptoms
Original Approved Country/TerritoryN/A
Original Approved Date1988/01/01
Country/TerritoryUnited StatesEUHong Kong +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme (Asia) LtdZentiva Ks
Inactive CompaniesDana-Farber Cancer InstituteSchaper & Bruemmer Gmbh & Co KgOrganon & Co
Active IndicationsMenopausal symptoms
Inactive IndicationsSexual Dysfunction, PhysiologicalOsteoporosis, PostmenopausalOsteoporosis +[4] 

Other Information

ATC CodeG03CX01
Related LinksWikipediaDrugBankKEGG